批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2009/07/01 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2023/10/23 |
SUPPL-30(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2023/10/23 |
SUPPL-28(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2020/11/16 |
SUPPL-29(补充) |
Approval |
Labeling-Medication Guide,Labeling-Patient Package Insert,Labeling-Package Insert |
STANDARD
|
|
|
| 2016/02/12 |
SUPPL-27(补充) |
Approval |
REMS-Modified |
N/A
|
|
|
| 2014/03/31 |
SUPPL-25(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2014/03/19 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 2014/03/19 |
SUPPL-24(补充) |
Approval |
REMS-Assessment |
N/A
|
|
|
| 2014/03/19 |
SUPPL-22(补充) |
Approval |
REMS-Modified |
N/A
|
|
|
| 2014/01/30 |
SUPPL-23(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2013/03/27 |
SUPPL-21(补充) |
Approval |
Labeling-Medication Guide |
STANDARD
|
|
|
| 2012/09/07 |
SUPPL-18(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2012/09/07 |
SUPPL-17(补充) |
Approval |
REMS-Assessment,REMS-Modified |
N/A
|
|
|
| 2012/09/07 |
SUPPL-16(补充) |
Approval |
Labeling-Medication Guide |
UNKNOWN
|
|
|
| 2012/06/13 |
SUPPL-14(补充) |
Approval |
REMS-Assessment,REMS-Modified |
N/A
|
|
|
| 2012/01/25 |
SUPPL-2(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
| 2011/12/19 |
SUPPL-13(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2011/08/22 |
SUPPL-12(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2011/08/05 |
SUPPL-6(补充) |
Approval |
REMS-Modified |
N/A
|
|
|
| 2011/06/21 |
SUPPL-10(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2011/03/11 |
SUPPL-7(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
| 2011/02/11 |
SUPPL-5(补充) |
Approval |
Labeling-Medication Guide |
UNKNOWN
|
|
|
| 2011/02/11 |
SUPPL-1(补充) |
Approval |
Labeling-Medication Guide |
STANDARD
|
|
|
| 2011/01/31 |
SUPPL-4(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:DRONEDARONE HYDROCHLORIDE; 剂型/给药途径:TABLET;ORAL; 规格:EQ 400MG BASE; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 022425 |
001 |
NDA |
MULTAQ |
DRONEDARONE HYDROCHLORIDE |
TABLET;ORAL |
EQ 400MG BASE |
Prescription |
Yes |
Yes |
AB |
2009/07/01
|
SANOFI AVENTIS US |
| 205904 |
001 |
ANDA |
DRONEDARONE HYDROCHLORIDE |
DRONEDARONE HYDROCHLORIDE |
TABLET;ORAL |
EQ 400MG BASE |
Prescription |
No |
No |
AB |
2024/01/31
|
LUPIN |